Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 57Other solid neoplasm 57Sarcoma 2Gynecologic 2Gastrointestinal 2Breast 2Lymphoid 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Lymphoma 41Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 28Lymphoma, Follicular 21Lymphoma, Large-Cell, Immunoblastic 17Hodgkin Disease 16Lymphoma, Mantle-Cell 15Burkitt Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 9Recurrence 8Lymphoma, Large-Cell, Anaplastic 8Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Extranodal NK-T-Cell 4Immunoblastic Lymphadenopathy 4Neoplasm Metastasis 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Mesothelioma 2Lymphoma, T-Cell 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uveal Melanoma 1Sezary Syndrome 1Primary Myelofibrosis 1

Interventions

enzalutamide 1entinostat 1abemaciclib 1Polymerase Chain Reaction 1Pemetrexed 1Paclitaxel 1Midazolam 1Microarray Analysis 1Letrozole 1LY3023414 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fulvestrant 1Flow Cytometry 1Fentanyl 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Cisplatin × Lymphoid × Clear all
NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed
156 enrolled
BreastLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡